Product Name:

NebuPeptide™ Liraglutide (Peptide Reference)

Catalog Number:

NBS-233760

Description:

NebuPeptide™ Liraglutide (Peptide Reference)(CAT#NBS-233760) is synthesized in accordance with the Liraglutide sequence and can be utilized for a variety of in vivo and in vitro studies, including quality control, bioactivity verification, immunization, drug development, structural analysis, etc. Nebula Biotechnology Co., Ltd. is capable of providing Insulin Aspart reference peptide ranging from milligrams to kilograms.

Peptide Name:

Liraglutide

Background:

Liraglutide, a Glucagon-like Peptide 1 (GLP-1) analog, is a potent agonist of the Glucagon-like Peptide 1 receptor. It is prescribed to patients with type 2 diabetes mellitus who do not respond to metformin as an anti-hyperglycemic agent and additional therapy.

Alias:

NNC 90-1170; Liraglutide; NN 2211; NN-2211; NN2211; trade names: Saxenda; Victoza; Liraglutida; Liraglutidum

CAS Number:

204656-20-2

Formula:

C172H265N43O51

Molecular Weight:

3751.2

Purity:

see COA

Solubility:

see COA

Storage & Shipment:

Store at -20℃; ship with blue ice.

For R&D use only!

To get more information, please contact us freely.